Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID | KEGG ID ▼ | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF02 |
|
44260853 | 2172.1301 | C98H173N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF03 |
|
44260854 | 2200.1614 | C100H177N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF04 |
|
44260855 | 2228.1927 | C102H181N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF05 |
|
44260856 | 2256.224 | C104H185N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF06 |
|
44260857 | 2284.2553 | C106H189N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF07 |
|
44260858 | 2254.20835 | C104H183N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BF08 |
|
44260859 | 2282.23965 | C106H187N5O47 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG01 |
|
44260860 | 2306.151625 | C102H179N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG02 |
|
44260861 | 2334.182925 | C104H183N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG03 |
|
44260862 | 2362.214225 | C106H187N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG04 |
|
44260863 | 2390.245525 | C108H191N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG05 |
|
44260864 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG06 |
|
44260865 | 2446.308125 | C112H199N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG07 |
|
44260866 | 2416.261175 | C110H193N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG08 |
|
44260867 | 2444.292475 | C112H197N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH01 |
|
44260868 | 1998.04089 | C90H159N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH02 |
|
44260869 | 2026.07219 | C92H163N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH03 |
|
44260870 | 2054.10349 | C94H167N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH04 |
|
44260871 | 2082.13479 | C96H171N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH05 |
|
44260872 | 2110.16609 | C98H175N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH06 |
|
44260873 | 2138.19739 | C100H179N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH07 |
|
44260874 | 2108.15044 | C98H173N5O43 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BH08 |
|
44260875 | 2136.18174 | C100H177N5O43 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024